For the year ending 2025-12-31, BIOA made $8,995K in revenue. -$80,572K in net income. Net profit margin of -895.74%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 8,995 | |||
| Research and development | 73,966 | |||
| General and administrative | 27,809 | |||
| Total operating expenses | 101,775 | |||
| Loss from operations | -92,780 | |||
| Interest expense | 697 | |||
| Interest and other income (expense), net | 13,086 | |||
| Gain (loss) from changes in fair value of warrants | -214 | |||
| Loss on extinguishment of debt | 0 | |||
| Total other income (expense), net | 12,175 | |||
| Net loss | -80,605 | |||
| Unrealized holding gains on available-for-sale investments | 122 | |||
| Foreign currency translation adjustment | -89 | |||
| Total other comprehensive income | 33 | |||
| Total comprehensive loss | -80,572 | |||
| Basic EPS | -2.24 | |||
| Diluted EPS | -2.24 | |||
| Basic Average Shares | 35,932,914 | |||
| Diluted Average Shares | 35,932,914 | |||
BioAge Labs, Inc. (BIOA)
BioAge Labs, Inc. (BIOA)